In This Article:
Morning Brief host Brad Smith tracks several of this morning's trending stocks and market stories, including Micron Technology's (MU) guidance overshadowing its fiscal second quarter results, Johnson & Johnson's (JNJ) plans to invest in US manufacturing, and AstraZeneca's (AZN) own investment into a Beijing facility.
To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.
We're taking a closer look at some trending tickers this morning, doing it in 30 seconds. Let's go. First up, Micron's margin outlook is overshadowing a positive second quarter earnings report. The chipmaker sees adjusted gross margin for the third quarter at the upper end of Wall Street's estimates. Plus, Johnson & Johnson will spend $55 billion in the US over the next four years on manufacturing, research and development, and tech investments. That marks a 25% increase in investment compared to the previous four years. And finally, AstraZeneca will invest $2.5 billion in a new research center in Beijing, in a show of confidence, months after a top executive from the company was detained there by authorities. This is AstraZeneca's second strategic R&D center in China, and it will feature advanced early-stage research and clinical development enabled by an AI and data science lab.
